IBDoc from a Nurse Perspective
At this year’s ECCO we took the chance to record an interview with Anita Beyer, an IBD Nurse in Vienna, who has been using IBDoc® for over a year:
IBDoc from a Nurse Perspective Read More »
BÜHLMANN at ECCO 2016
At the last European Crohn’s and Colitis Congress in Amsterdam we took the chance to record a video of our congress presence as well as a two interviews: One with an IBD Nurse, Anita Beyer, from the General Hospital in Vienna (AKH), who has been using IBDoc® since over one year and another interview with
BÜHLMANN at ECCO 2016 Read More »
IBDoc TGA approved for Australia
IBDoc® is now available in Australia. IBDoc® achieved the CE certification in April 2015 for self-testing making it available to patients throughout Europe. Now a second major milestone has been reached. The Australian Health Authorities TGA (Therapeutic Goods Administration), approved the use of IBDoc®. This means that IBDoc® can now be made available to all Australian IBD patients
IBDoc TGA approved for Australia Read More »
Can mHealth Apps replace clinic visits
In a recent article in the Journal of mHealth (Volume 3, Issue 3), McCombie and colleagues performed a systematic review of IBD symptom monitoring smartphone apps. They found 233 separate apps on Google Play Store (Android) and Apple App Store (iPhone) that matched their search criteria for IBD. Out of this inital apps they included
Can mHealth Apps replace clinic visits Read More »
IBDoc is now available in Polish
In addition to Czech, Hungarian, Estonian and Croatian, IBDoc is now also available in Polish. You can find the instruction for use in Polish here.
IBDoc is now available in Polish Read More »
IBDoc® is now available in 17 languages
Today we added 4 more language translations to IBDoc® and it is now available in: Danish Czech Croatian Hungarian IBDoc® is not supported in 17 languages
IBDoc® is now available in 17 languages Read More »
Calprotectin Video from CDHF
The Canadian Digestive Health Foundation (CDHF) has recently produced a very interesting video about the use of calprotectin to confirm and predict flares in inflammatory bowel disease patients and how it can be used to manage IBD. By loading the video, you agree to YouTube’s privacy policy.Learn more Load video Always unblock YouTube
Calprotectin Video from CDHF Read More »
UEGW 2015 News
This year the United European Gastroenterology Week took place from October 24th to 28th in Barcelona. Over 13 000 participants from 114 countries were present. The BÜHLMANN team was among the 2325 exhibitors. This year’s UEGW marked an important event for us with the publication of the first clinical usability evaluation of IBDoc®. The data
First Patient Feedback
Patient M.K. was one of the first patient to use IBDoc world wide during an early project in Vienna. M.K. is suffering from Crohn’s Disease and after the first couple of months of using IBDoc we received following statement: [testimonials][testimonial author=”M.K. from Vienna” job=”Student & Crohn’s Patient “] I think that IBDoc is very useful
First Patient Feedback Read More »
BÜHLMANN launches IBDoc® – the first CE marked Calprotectin Home Test
Basel, April 2nd, 2015 – BÜHLMANN is pleased to announce the launch of IBDoc®, the first in-vitro diagnostic test to measure the fecal inflammation marker calprotectin at home. IBDoc® just received a CE mark for patient self testing and is a revolutionary new test for gut inflammation aimed at people with Inflammatory Bowel Disease, Crohn’s and Ulcerative Colitis
BÜHLMANN launches IBDoc® – the first CE marked Calprotectin Home Test Read More »